Physician profile
Bruce Miller
NPI 1740278225
$69,352.98
in general payments reported to CMS, 2019-2025
27 companies · $172 in 2025
The $172 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44K · 2020: $16K · 2021: $2,531 · 2022: $6,299 · 2023: $83.49 · 2024: $171 · 2025: $172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $426.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $426.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $62,358.15 | 2019-2022 | |
| Depuy Synthes Products, INC. | $3,869.37 | 2019-2022 | |
| Arthrex, INC. | $1,231.06 | 2019 | |
| Depuy Synthes Sales INC. | $1,126.61 | 2019-2024 | Healix Knotless Peek, Dynatape |
| Stryker Corporation | $131.64 | 2024-2025 | Tritanium, Iconix, Alphavent |
| Pacira Therapeutics, INC. | $108.62 | 2019-2021 | |
| Djo, LLC | $89.67 | 2021-2025 | Cmf |
| Ferring Pharmaceuticals INC. | $57.24 | 2021-2025 | Euflexxa |
| Pacira Pharmaceuticals Incorporated | $35.79 | 2024 | Iovera, Zilretta |
| Globus Medical, INC. | $32.59 | 2025 | Senza |
| Convatec INC. | $32.42 | 2019-2021 | |
| Abbvie INC. | $30.02 | 2022-2023 | |
| Fidia Pharma USA INC. | $29.84 | 2022 | |
| Biocomposites INC | $26.24 | 2023 | Stimulan |
| Si-Bone, INC. | $23.15 | 2025 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $20.97 | 2021 | |
| Anika Therapeutics, INC. | $16.81 | 2021 | |
| Medartis INC. | $16.72 | 2019 | |
| Ethicon US, LLC | $15.95 | 2019 | |
| Endo Pharmaceuticals INC. | $15.61 | 2021 | |
| Linvatec Corporation | $15.01 | 2023 | Linvatec Extremities, Biobrace 23mm |
| Zyla Life Sciences, INC. | $13.23 | 2020 | |
| Horizon Therapeutics Plc | $13.18 | 2022 | |
| Amgen INC. | $13.07 | 2019 | |
| Bioventus LLC | $12.80 | 2021 | |
| Heron Therapeutics, INC. | $11.65 | 2021 | |
| Medela LLC | $5.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.